ArticleBMC cancer2026

Human single domain antibody-based CAR-T cells targeting BAFF-R demonstrate promising preclinical activity in B-cell malignancies.

Cuiling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.